EP1003770A4 - Proteines secretees et polynucleotides codant ces proteines - Google Patents
Proteines secretees et polynucleotides codant ces proteinesInfo
- Publication number
- EP1003770A4 EP1003770A4 EP98930279A EP98930279A EP1003770A4 EP 1003770 A4 EP1003770 A4 EP 1003770A4 EP 98930279 A EP98930279 A EP 98930279A EP 98930279 A EP98930279 A EP 98930279A EP 1003770 A4 EP1003770 A4 EP 1003770A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- polynucleotides encoding
- secreted proteins
- secreted
- proteins
- polynucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Transplantation (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98588 | 1979-11-29 | ||
US87871597A | 1997-06-19 | 1997-06-19 | |
US878715 | 1997-06-19 | ||
US9858898A | 1998-06-17 | 1998-06-17 | |
PCT/US1998/012516 WO1998057976A1 (fr) | 1997-06-19 | 1998-06-18 | Proteines secretees et polynucleotides codant ces proteines |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1003770A1 EP1003770A1 (fr) | 2000-05-31 |
EP1003770A4 true EP1003770A4 (fr) | 2002-10-30 |
Family
ID=26794899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98930279A Withdrawn EP1003770A4 (fr) | 1997-06-19 | 1998-06-18 | Proteines secretees et polynucleotides codant ces proteines |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1003770A4 (fr) |
JP (1) | JP2002513294A (fr) |
AU (1) | AU7970498A (fr) |
CA (1) | CA2294569A1 (fr) |
WO (1) | WO1998057976A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001040271A2 (fr) * | 1999-12-01 | 2001-06-07 | Ludwig Institute For Cancer Research | Antigenes associes au cancer et utilisations correspondantes |
JP5504562B2 (ja) * | 2006-12-20 | 2014-05-28 | 東レ株式会社 | 癌の検出方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4798885A (en) * | 1986-02-07 | 1989-01-17 | Genentech, Inc. | Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain |
US5770209A (en) * | 1991-08-30 | 1998-06-23 | University Of South Florida | Acceleration of wound healing using connective tissue growth factor |
US5536637A (en) * | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
CZ343795A3 (en) * | 1993-06-29 | 1996-07-17 | Chiron Corp | Shortened keratinocyte growth factor /kgf/ exhibiting increased biological activity |
US5707829A (en) * | 1995-08-11 | 1998-01-13 | Genetics Institute, Inc. | DNA sequences and secreted proteins encoded thereby |
US5708157A (en) * | 1996-07-26 | 1998-01-13 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
US5792628A (en) * | 1997-03-14 | 1998-08-11 | Bowman; Michael | Secreted protein, BA3.1, and polynucleotides encoding same |
-
1998
- 1998-06-18 CA CA002294569A patent/CA2294569A1/fr not_active Abandoned
- 1998-06-18 WO PCT/US1998/012516 patent/WO1998057976A1/fr not_active Application Discontinuation
- 1998-06-18 AU AU79704/98A patent/AU7970498A/en not_active Abandoned
- 1998-06-18 EP EP98930279A patent/EP1003770A4/fr not_active Withdrawn
- 1998-06-18 JP JP50468199A patent/JP2002513294A/ja active Pending
Non-Patent Citations (5)
Title |
---|
DATABASE EMBL [online] 30 June 1993 (1993-06-30), XP002209843, Database accession no. L20259 * |
DATABASE EMBL [online] XP002209844, Database accession no. L14938 * |
DATABASE EMBL [online] XP002209845, Database accession no. AB007912 * |
OKAZAKI TAKASHI ET AL: "Molecular diversity of the SCG10/stathmin gene family in the mouse.", GENOMICS, vol. 18, no. 2, 1993, pages 360 - 373, XP002209842, ISSN: 0888-7543 * |
See also references of WO9857976A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2294569A1 (fr) | 1998-12-23 |
EP1003770A1 (fr) | 2000-05-31 |
WO1998057976A1 (fr) | 1998-12-23 |
JP2002513294A (ja) | 2002-05-08 |
AU7970498A (en) | 1999-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6050898A (en) | Secreted proteins and polynucleotides encoding them | |
AU6777298A (en) | Secreted proteins and polynucleotides encoding them | |
AU6578398A (en) | Secreted proteins and polynucleotides encoding them | |
AU7159898A (en) | Secreted proteins and polynucleotides encoding them | |
AU7807298A (en) | Secreted proteins and polynucleotides encoding them | |
AU6702298A (en) | Secreted proteins and polynucleotides encoding them | |
AU1101199A (en) | Secreted proteins and polynucleotides encoding them | |
EP1056764A4 (fr) | Proteines secretees et polynucleotides codant lesdites proteines | |
AU7142498A (en) | Secreted proteins and polynucleotides encoding them | |
AU1417899A (en) | Secreted proteins and polynucleotides encoding them | |
EP1075487A4 (fr) | Proteines secretees et polynucleotides les codant | |
AU6337398A (en) | Secreted proteins and polynucleotides encoding them | |
AU5828398A (en) | Secreted proteins and polynucleotides encoding them | |
AU6590898A (en) | Secreted proteins and polynucleotides encoding them | |
EP1012261A4 (fr) | Proteines secretees et polynucleotides les codant | |
AU5801998A (en) | Secreted proteins and polynucleotides encoding them | |
AU6546898A (en) | Secreted proteins and polynucleotides encoding them | |
EP1040118A4 (fr) | Proteines secretees et polynucleotides les codant | |
AU7826498A (en) | Secreted proteins and polynucleotides encoding them | |
EP1017719A4 (fr) | Proteines secretees et polynucleotides les codant | |
AU6765098A (en) | Secreted proteins and polynucleotides encoding them | |
EP1003770A4 (fr) | Proteines secretees et polynucleotides codant ces proteines | |
EP1032652A4 (fr) | Proteines secretees et polynucleotides codant ces proteines | |
AU6439598A (en) | Secreted proteins and polynucleotides encoding them | |
AU5958698A (en) | Secreted proteins and polynucleotides encoding them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000119 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: HOWES, STEVEN, H. Inventor name: AGOSTINO, MICHAEL, J. Inventor name: SPAULDING, VIKKI Inventor name: TREACY, MAURICE Inventor name: RACIE, LISA, A. Inventor name: LAVALLIE, EDWARD, R. Inventor name: MCCOY, JOHN, M. Inventor name: JACOBS, KENNETH |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: HOWES, STEVEN, H. Inventor name: AGOSTINO, MICHAEL, J. Inventor name: SPAULDING, VIKKI Inventor name: TREACY, MAURICE Inventor name: RACIE, LISA, A. Inventor name: LAVALLIE, EDWARD, R. Inventor name: MCCOY, JOHN, M. Inventor name: JACOBS, KENNETH |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: GENETICS INSTITUTE, LLC |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020916 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20030131 |